University Hospital Ostrava
Ostrava, Czech Republic, 70852, Czechia
NCT Number: NCT02360137
Atherosclerosis is the most common cause of stroke. The aims of the project are to compare the visual and digital analysis of sonographic images of atherosclerotic plaque in carotids in vivo, in vitro and with a histological composition of the plaque obtained from patients indicated to carotid endarterectomy, to compare the characteristics of symptomatic and asymptomatic atherosclerotic plaques and, subsequently to verify a hypothesis that ultrasound can identify the sonographic plaque characteristics associated with an increased risk of plaque progression and of ischemic stroke (unstable plaque) in patients with carotid atherosclerosis. Identifying of the sonographic characteristics of unstable plaque will allow to improve indication criteria for carotid endarterectomy or stenting and also potential changing of a drug therapy in patients with unstable plaque in the future. Cost efficiency and availability of duplex ultrasound equipment may enable to improve diagnosis of unstable plaque using this new plaque characteristics evaluation in the majority of patients with carotid plaques.
Secondary aim is to evaluate prevalence of carotid web and risk of stroke in patients with atherosclerotic plaque in carotid arteries and healthy population.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Ostrava, Czech Republic, 70852, Czechia
Objectives and aims The objective of the project is to identify measurable features of atherosclerotic plaque in carotids associated with plaque progression and increased stroke/TIA risk using duplex sonography and digital B-mode image analysis.
The project aims
5/ assess the prevalence of carotid web and risk of stroke in patients with atherosclerotic plaque in carotid arteries and healthy population 6/ to assess the longitudinal prevalence and associated cerebrovascular risks with ultrasound-detected carotid web
The grant project is in concordance with the scope, expected benefits, key objective of the Programme "Ensuring internationally comparable levels of healthcare research and use the results to improve the health of Czech population and to secure the current needs of the health sector in the Czech Republic" and the sub-objective 1.2.2. "The development of early diagnosis of cardiovascular and cerebrovascular disease and finding treatment modalities and procedures in the treatment of cardiovascular and cerebrovascular disease with greater therapeutic efficiency and greater parsimony for the patient."
Project design
Inclusion criteria
1/ age 30 - 90 years, 2/ sufficient image quality of atherosclerotic plaque in the carotid bifurcation and ICA using ultrasound, 3/ independency of the patient (0 - 2 points in the modified Rankin scale), 4/ signed informed consent.
Exclusion criteria
1/ serious disease with a low probability of survival of at least 3 years, 2/ other objective obstacles preventing regular 6-month ultrasound scan.
Clinical examination: Physical and neurological examinations and examinations of carotid arteries by duplex sonography will be performed in all patients at baseline and every 6 months for 3 years.
For evaluation of prevalence of carotid web, totaly 250 healthy subjects will be enrolled.
The sample size for patients undergoing carotid endarterectomy with subsequent in vitro sonographic and histological evaluation of atherosclerotic plaques was based on an expected Spearman's correlation coefficient ≥ 0.3 between histological and sonographic evaluation of atherosclerotic plaque (visual and digital image analysis). Pre-study calculations showed that a minimum of 152 patients were needed to reach a significant difference with an alpha value of 0.01 (after Bonferroni correction for 5 evaluated factors) and a beta value of 0.8 assuming that 20 % of plaques will not be suitable for evaluation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years
Sonographic and histological characteristics associated with plaque progression
Time frame: 10 years
Sonographic and histological characteristics associated with stroke or TIA risks, such as homogeneity, composition, echogenity index, plaque surface type
Time frame: 10 years
Sonographic and histological characteristics associated with mortality, such as homogeneity, composition, echogenity index, plaque surface type
Time frame: 1 year
Sonographic plaque characteristics correlation, using Spearman correlation coefficient to verify the existence of correlations between carotid atherosclerotic plaque in a B-mode in vivo (before endarterectomy) and subsequently in a B-mode in vitro (after endarterectomy) in homogeneity, composition, echogenity index, plaque surface type
Time frame: 1 year
Histological and sonographic plaque characteristics correlation, using Spearman correlation coefficient to verify the existence of correlations between variables - homogeneity, composition, echogenity index, plaque surface type
Time frame: Baseline
Prevalence of carotid web
Time frame: Through study completion, an average of 10 years
Newly detected carotid web
University Hospital Ostrava
Other
Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque and a Risk of Stroke in Patients With the carotId Bifurcation Plaque Study
Acronym: ANTIQUE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05134493
Arterial Occlusive Diseases, Brain Diseases
Modena, Italy
View Trial DetailsNCT02726984
Arterial Occlusive Diseases, Brain Diseases
Bron, France
View Trial DetailsNCT06933745
Arterial Occlusive Diseases, Arteriosclerosis
Oslo, East, Norway
View Trial DetailsNCT02476396
Arterial Occlusive Diseases, Brain Diseases
Madison, Wisconsin, United States
View Trial Details